Drug Type Small molecule drug |
Synonyms RP-5090 |
Target |
Action inhibitors |
Mechanism PI3Kδ inhibitors(Phosphatidylinositol 3 kinase delta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pulmonary Disease, Chronic Obstructive | Preclinical | India | 13 Nov 2022 | |
| Asthma | Discovery | India | - | |
| Asthma | Discovery | Switzerland | - | |
| Liver Injury | Discovery | India | - | |
| Liver Injury | Discovery | Switzerland | - |





